Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.

Mass drug administration (MDA) programmes against Onchocerca volvulus use ivermectin (IVM) which targets microfilariae (MF), the worm's offspring. Most infected individuals are hyporesponsive and present regulated immune responses despite high parasite burden. Recently, with MDA programmes, the...

Full description

Bibliographic Details
Main Authors: Kathrin Arndts, Sabine Specht, Alexander Y Debrah, Francesca Tamarozzi, Ute Klarmann Schulz, Sabine Mand, Linda Batsa, Alexander Kwarteng, Mark Taylor, Ohene Adjei, Coralie Martin, Laura E Layland, Achim Hoerauf
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-02-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3930501?pdf=render
id doaj-d04844ed209f407b92bb0b3b2ff432a5
record_format Article
spelling doaj-d04844ed209f407b92bb0b3b2ff432a52020-11-25T01:36:58ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-02-0182e267910.1371/journal.pntd.0002679Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.Kathrin ArndtsSabine SpechtAlexander Y DebrahFrancesca TamarozziUte Klarmann SchulzSabine MandLinda BatsaAlexander KwartengMark TaylorOhene AdjeiCoralie MartinLaura E LaylandAchim HoeraufMass drug administration (MDA) programmes against Onchocerca volvulus use ivermectin (IVM) which targets microfilariae (MF), the worm's offspring. Most infected individuals are hyporesponsive and present regulated immune responses despite high parasite burden. Recently, with MDA programmes, the existence of amicrofilaridermic (a-MF) individuals has become apparent but little is known about their immune responses. Within this immunoepidemiological study, we compared parasitology, pathology and immune profiles in infection-free volunteers and infected individuals that were MF(+) or a-MF. The latter stemmed from villages in either Central or Ashanti regions of Ghana which, at the time of the study, had received up to eight or only one round of MDA respectively. Interestingly, a-MF patients had fewer nodules and decreased IL-10 responses to all tested stimuli. On the other hand, this patient group displayed contrary IL-5 profiles following in vitro stimulation or in plasma and the dampened response in the latter correlated to reduced eosinophils and associated factors but elevated neutrophils. Furthermore, multivariable regression analysis with covariates MF, IVM or the region (Central vs. Ashanti) revealed that immune responses were associated with different covariates: whereas O. volvulus-specific IL-5 responses were primarily associated with MF, IL-10 secretion had a negative correlation with times of individual IVM therapy (IIT). All plasma parameters (eosinophil cationic protein, IL-5, eosinophils and neutrophils) were highly associated with MF. With regards to IL-17 secretion, although no differences were observed between the groups to filarial-specific or bystander stimuli, these responses were highly associated with the region. These data indicate that immune responses are affected by both, IIT and the rounds of IVM MDA within the community. Consequently, it appears that a lowered infection pressure due to IVM MDA may affect the immune profile of community members even if they have not regularly participated in the programmes.http://europepmc.org/articles/PMC3930501?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kathrin Arndts
Sabine Specht
Alexander Y Debrah
Francesca Tamarozzi
Ute Klarmann Schulz
Sabine Mand
Linda Batsa
Alexander Kwarteng
Mark Taylor
Ohene Adjei
Coralie Martin
Laura E Layland
Achim Hoerauf
spellingShingle Kathrin Arndts
Sabine Specht
Alexander Y Debrah
Francesca Tamarozzi
Ute Klarmann Schulz
Sabine Mand
Linda Batsa
Alexander Kwarteng
Mark Taylor
Ohene Adjei
Coralie Martin
Laura E Layland
Achim Hoerauf
Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
PLoS Neglected Tropical Diseases
author_facet Kathrin Arndts
Sabine Specht
Alexander Y Debrah
Francesca Tamarozzi
Ute Klarmann Schulz
Sabine Mand
Linda Batsa
Alexander Kwarteng
Mark Taylor
Ohene Adjei
Coralie Martin
Laura E Layland
Achim Hoerauf
author_sort Kathrin Arndts
title Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
title_short Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
title_full Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
title_fullStr Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
title_full_unstemmed Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
title_sort immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2014-02-01
description Mass drug administration (MDA) programmes against Onchocerca volvulus use ivermectin (IVM) which targets microfilariae (MF), the worm's offspring. Most infected individuals are hyporesponsive and present regulated immune responses despite high parasite burden. Recently, with MDA programmes, the existence of amicrofilaridermic (a-MF) individuals has become apparent but little is known about their immune responses. Within this immunoepidemiological study, we compared parasitology, pathology and immune profiles in infection-free volunteers and infected individuals that were MF(+) or a-MF. The latter stemmed from villages in either Central or Ashanti regions of Ghana which, at the time of the study, had received up to eight or only one round of MDA respectively. Interestingly, a-MF patients had fewer nodules and decreased IL-10 responses to all tested stimuli. On the other hand, this patient group displayed contrary IL-5 profiles following in vitro stimulation or in plasma and the dampened response in the latter correlated to reduced eosinophils and associated factors but elevated neutrophils. Furthermore, multivariable regression analysis with covariates MF, IVM or the region (Central vs. Ashanti) revealed that immune responses were associated with different covariates: whereas O. volvulus-specific IL-5 responses were primarily associated with MF, IL-10 secretion had a negative correlation with times of individual IVM therapy (IIT). All plasma parameters (eosinophil cationic protein, IL-5, eosinophils and neutrophils) were highly associated with MF. With regards to IL-17 secretion, although no differences were observed between the groups to filarial-specific or bystander stimuli, these responses were highly associated with the region. These data indicate that immune responses are affected by both, IIT and the rounds of IVM MDA within the community. Consequently, it appears that a lowered infection pressure due to IVM MDA may affect the immune profile of community members even if they have not regularly participated in the programmes.
url http://europepmc.org/articles/PMC3930501?pdf=render
work_keys_str_mv AT kathrinarndts immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT sabinespecht immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT alexanderydebrah immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT francescatamarozzi immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT uteklarmannschulz immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT sabinemand immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT lindabatsa immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT alexanderkwarteng immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT marktaylor immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT oheneadjei immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT coraliemartin immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT lauraelayland immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
AT achimhoerauf immunoepidemiologicalprofilingofonchocerciasispatientsrevealsassociationswithmicrofilarialoadsandivermectinintakeonbothindividualandcommunitylevels
_version_ 1725060525840138240